NOVARTIS INDIA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,059 INR | -0.29% |
|
+2.30% | +36.94% |
| 04-01 | Novartis India Limited Announces Resignation of Nikhil Malpani as Company Secretary and Compliance Officer, Effective from April 30, 2024 | CI |
| 03-22 | Novartis Eyes Sale of Listed Unit in India | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 314M | - | - | - | - | - | |
| 690B | ||||||
| 546B | ||||||
| 358B | ||||||
| 323B | ||||||
| 287B |
